Louisiana's legal challenge to federal abortion pill regulations has moved through the federal courts with significant momentum. The state sued the FDA seeking to eliminate telehealth and mail-order access to mifepristone, the medication used in medication abortion procedures. On May 1, the Fifth Circuit Court of Appeals issued a ruling that restricted how the drug can be distributed, even as the case proceeds toward the Supreme Court.
The Fifth Circuit's decision narrowed FDA guidelines that had expanded access to mifepristone during the COVID-19 pandemic. Those rules allowed patients to receive the drug remotely and by mail rather than requiring in-person clinic visits. The court's ruling reinstated stricter requirements, effectively limiting where and how women can obtain the medication.
The case reflects the larger abortion landscape after the Supreme Court's 2022 Dobbs decision, which eliminated the federal constitutional right to abortion and returned authority to states. Louisiana and other Republican-led states have pursued aggressive restrictions on abortion access. This litigation represents a new front in those efforts, targeting the FDA's regulatory authority rather than relying solely on state criminal bans.
The Supreme Court faces a fundamental question about the FDA's power to regulate medication abortion nationally. If the justices side with Louisiana, they could upend federal drug approval standards and complicate efforts by abortion-rights advocates to maintain access across state lines. The decision could also affect how courts handle other FDA regulations going forward.
The case sits at the intersection of drug regulation, federalism, and abortion politics. A ruling for Louisiana would empower states to challenge federal decisions about pharmaceutical approval and distribution. A ruling for the Biden administration would preserve the FDA's traditional authority to set national drug standards based on scientific evidence. The Supreme Court's decision will reshape how abortion access works in America and potentially reshape administrative law more broadly.